Clare A. Balendran

487 total citations · 1 hit paper
11 papers, 394 citations indexed

About

Clare A. Balendran is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Clare A. Balendran has authored 11 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Clare A. Balendran's work include Trauma, Hemostasis, Coagulopathy, Resuscitation (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Clare A. Balendran is often cited by papers focused on Trauma, Hemostasis, Coagulopathy, Resuscitation (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Clare A. Balendran collaborates with scholars based in Sweden, United Kingdom and Denmark. Clare A. Balendran's co-authors include Gerhard Böttcher, Mark Berner Hansen, Anna Reznichenko, Silvio Danese, Ib Groth Clausen, Carina Kärrman Mårdh, Mohib Uddin, Thomas T. MacDonald, Daniel Muthas and Ryan S. Huss and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and European Heart Journal.

In The Last Decade

Clare A. Balendran

10 papers receiving 386 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial

2022 157 citations Naim Alkhouri, Robert Herring et al. Journal of Hepatology profile →

Peers

Clare A. Balendran

EPIDE

GENET

EDM

IMMUN

Zun Xiang China

Seol Hee Park United States

Michael Dudek Germany

Daria Vay Italy

David Marais South Africa

Nobuhito Taniki Japan

Woo-Kyu Jeon South Korea

Xiaoqiang Yan China

Traci E. Stankiewicz United States

Natsuko Hada Japan

Zun Xiang China

Clare A. Balendran

216 ×1.4

EPIDE

259 ×2.3

55 ×0.6

GENET

60 ×0.7

EDM

48 ×0.6

IMMUN

Citations per year, relative to Clare A. Balendran Clare A. Balendran (= 1×) peers Zun Xiang

Countries citing papers authored by Clare A. Balendran

Since Specialization

Citations

This map shows the geographic impact of Clare A. Balendran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare A. Balendran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare A. Balendran more than expected).

Fields of papers citing papers by Clare A. Balendran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare A. Balendran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare A. Balendran. The network helps show where Clare A. Balendran may publish in the future.

Co-authorship network of co-authors of Clare A. Balendran

This figure shows the co-authorship network connecting the top 25 collaborators of Clare A. Balendran. A scholar is included among the top collaborators of Clare A. Balendran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clare A. Balendran. Clare A. Balendran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Ratziu, Vlad, Arun J. Sanyal, Vincent Wai‐Sun Wong, et al.. (2025). Exploration of Multiple Non‐Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients with MASH. Alimentary Pharmacology & Therapeutics. 63(3). 396–404.

Alkhouri, Naim, Robert Herring, Heidi Kabler, et al.. (2022). Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial. Journal of Hepatology. 77(3). 607–618. 157 indexed citations breakdown →

Ericsson, Hans, Karin Nelander, Maria Lagerström‐Fermér, et al.. (2018). Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5‐Lipoxygenase Activating Protein Inhibitor. Clinical and Translational Science. 11(3). 330–338. 22 indexed citations

Balendran, Clare A., Richard Harris, Victor P. Bondanese, et al.. (2018). MicroRNA-31 Targets Thymic Stromal Lymphopoietin in Mucosal Infiltrated CD4+ T Cells: A Role in Achieving Mucosal Healing in Ulcerative Colitis?. Inflammatory Bowel Diseases. 24(11). 2377–2385. 13 indexed citations

Balendran, Clare A., Neil Henderson, Marita Olsson, Ann Lövgren, & Kenny M. Hansson. (2017). Preclinical evaluation of point‐of‐care prothrombin time as a biomarker test to guide prothrombin replacement therapy in coagulopathic bleeding. Research and Practice in Thrombosis and Haemostasis. 1(2). 252–258. 3 indexed citations

Balendran, Clare A., Ann Lövgren, Kenny M. Hansson, et al.. (2017). Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 25(1). 30–30. 11 indexed citations

Balendran, Clare A., Niclas Eriksson, Carl Whatling, et al.. (2017). P3247Polymorphisms of the ALOX5AP gene (5-lipoxygenase activating protein) are associated with increased cardiovascular risk in patients with acute coronary syndrome: Analysis of PLATO genetics sub-study. European Heart Journal. 38(suppl_1). 2 indexed citations

Russell, Muir, Nina Prokoph, Neil Henderson, et al.. (2017). Determining myeloperoxidase activity and protein concentration in a single assay: Utility in biomarker and therapeutic studies. Journal of Immunological Methods. 449. 76–79. 6 indexed citations

Randall, Kevin J., Neil Henderson, Ann‐Christin Nyström, et al.. (2016). Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies. PLoS ONE. 11(9). e0162076–e0162076. 18 indexed citations

10.

Muthas, Daniel, Anna Reznichenko, Clare A. Balendran, et al.. (2016). Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications. Scandinavian Journal of Gastroenterology. 52(2). 125–135. 141 indexed citations

11.

Lind, Ulrika, Tina Nilsson, Jane McPheat, et al.. (2005). Identification of the human ApoAV gene as a novel RORα target gene. Biochemical and Biophysical Research Communications. 330(1). 233–241. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact